Post

New research · Ophthalmology
BMJ case reports · 4d
Case reportBMJ case reports · 2026

Significant clinical, functional and radiological response with sirolimus in refractory complex orbital venolymphatic malformation.

Ankita Aishwarya, Rachna Agarwal, Vaibhav Jain
Read paper
OphthalmologyCase report

Sirolimus treatment was followed by marked visual improvement in a child with refractory orbital malformation.

Significant clinical, functional and radiological response with sirolimus in refractory complex orbital venolymphatic malformation.

Ankita Aishwarya … Vaibhav Jain
BMJ case reports · 2026
Background

Orbital venolymphatic malformations (orbital venolymphatic malformations) are rare congenital vascular anomalies that may cause progressive proptosis, visual loss, facial disfigurement and marked psychosocial burden.

6/9-2
Results
6/9-2
vision sharper still: reading almost normal-size letters, up from finger-counting
More results

Management is challenging especially when the disease is multifocal, diffuse and with limited response to conventional therapies.

After multidisciplinary evaluation, oral sirolimus was initiated with written informed consent from the parents in a refractory setting.

The child resumed normal activities.

“
Conclusion

This case highlights the potential role of systemic mechanistic target of rapamycin (mTOR) inhibition in complex, refractory orbital venolymphatic malformations and highlights careful patient selection and long-term follow-up.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment